Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management

Myasthenia gravis (MG) is the most common autoimmune disorder affecting the neuromuscular junction, characterized by skeletal muscle weakness and fatigability. It is caused by autoantibodies targeting proteins of the neuromuscular junction; ~85% of MG patients have autoantibodies against the muscle...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazaridis, Konstantinos, Tzartos, Socrates J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734299/
https://www.ncbi.nlm.nih.gov/pubmed/33329350
http://dx.doi.org/10.3389/fneur.2020.596981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734299/
https://www.ncbi.nlm.nih.gov/pubmed/33329350
http://dx.doi.org/10.3389/fneur.2020.596981

Ejemplares similares